Solventum Corp (SOLV)
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Instruments & Supplies
Solventum Corporation
No splits on record
Nothing in SOLV's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $8.32B | $8.25B | $8.2B | $8.13B | $8.17B | $7.28B |
| YoY Growth | 0.9% | 0.7% | 0.8% | -0.5% | 12.2% | - |
| Cost of Revenue | $3.87B | $3.66B | $3.5B | $3.44B | $3.25B | $2.97B |
| Gross Profit | $4.45B | $4.59B | $4.69B | $4.7B | $4.92B | $4.32B |
| Gross Margin | 53.5% | 55.6% | 57.3% | 57.7% | 60.2% | 59.3% |
| Research and Development | $739M | $775M | $758M | $767M | $766M | $719M |
| Selling, General, and Administrative | $3.08B | $2.78B | $2.24B | $2.23B | $2.28B | $2.17B |
| Other | -$1.55B | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $2.27B | $3.56B | $3B | $3B | $3.04B | $2.88B |
| Operating Income (EBIT) | $2.18B | $1.04B | $1.69B | $1.69B | $1.88B | $1.43B |
| Operating Margin | 26.2% | 12.6% | 20.6% | 20.8% | 23.0% | 19.6% |
| Interest Expense | $347M | $367M | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$468M | -$431M | -$25M | -$1M | $3M | $10M |
| Income Before Tax (EBT) | $1.71B | $605M | $1.67B | $1.69B | $1.88B | $1.44B |
| Income Tax Expense | $157M | $127M | $321M | $349M | $422M | $302M |
| Net Income | $1.56B | $479M | $1.35B | $1.34B | $1.46B | $1.14B |
| Net Income Margin | 18.7% | 5.8% | 16.4% | 16.5% | 17.9% | 15.6% |
| Supplementary Data | ||||||
| EPS | 8.94 | 2.77 | 7.79 | 7.79 | 8.47 | 6.60 |
| Diluted EPS | 8.88 | 2.76 | 7.79 | 7.79 | 8.47 | 6.60 |
| Weighted Average OS | 174.10M | 173.20M | 172.71M | 172.47M | 172.47M | 172.47M |
| EBITDA | $2.55B | $1.53B | $2.23B | $2.27B | $2.48B | $2.03B |
| EBITDA Margin | 30.6% | 18.5% | 27.2% | 27.9% | 30.3% | 27.9% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Assets | |||||
| Current Assets | |||||
| Cash and Cash Equivalents | $878M | $762M | $194M | $61M | $91M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $878M | $762M | $194M | $61M | $91M |
| Accounts Receivable | $1.03B | $1.23B | $1.31B | $1.17B | $1.18B |
| Inventory | $1.07B | $965M | $857M | $873M | $813M |
| Other Current Assets | $881M | $293M | $155M | $126M | $108M |
| Total Current Assets | $3.86B | $3.25B | $2.52B | $2.23B | $2.19B |
| Long-Term Assets | |||||
| Property, Plant & Equipment Net | $1.33B | $1.62B | $1.46B | $1.32B | $1.31B |
| Goodwill | $5.7B | $6.38B | $6.54B | $6.43B | $6.67B |
| Intangible Assets | $2.59B | $2.54B | $2.9B | $3.25B | $3.66B |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $813M | $665M | $530M | $358M | $253M |
| Total Long-Term Assets | $10.44B | $11.21B | $11.42B | $11.36B | $11.89B |
| Other Assets | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $14.29B | $14.46B | $13.94B | $13.59B | $14.07B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | $687M | $618M | $477M | $348M | $320M |
| Short-Term Debt | $0 | $200M | $0 | $27M | $0 |
| Current Income Tax Payable | $0 | $122M | $106M | $0 | $0 |
| Current Unearned Revenue | $621M | $572M | $574M | $559M | $0 |
| Other Current Liabilities | $1.83B | $659M | $365M | $312M | $732M |
| Total Current Liabilities | $3.14B | $2.7B | $1.73B | $1.31B | $1.41B |
| Long-Term Liabilities | |||||
| Long-Term Debt | $5.04B | $7.81B | $8.3B | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $164M | $225M | $231M | $215M | $0 |
| Other Long-Term Liabilities | $910M | $760M | -$7.99B | $258M | $527M |
| Total Long-Term Liabilities | $6.11B | $8.79B | $549M | $541M | $610M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $9.24B | $11.5B | $2.28B | $1.85B | $2.02B |
| Stockholders' Equity | |||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $2M | $2M | $0 | $0 | $0 |
| Retained Earnings | $1.8B | $242M | $0 | $0 | $0 |
| Comprehensive Income & Other | -$625M | -$1.06B | -$337M | -$497M | -$200M |
| Other Stockholders' Equity | $3.25B | $2.71B | $11.67B | $11.74B | $12.06B |
| Total Equity | $5.05B | $2.96B | $11.67B | $11.74B | $12.06B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $14.29B | $14.46B | $13.94B | $13.59B | $14.07B |
| Supplementary Data | |||||
| Total Debt | $5.04B | $8.01B | $8.3B | $95M | $112M |
| Net Debt | $4.16B | $7.25B | $8.11B | $34M | $21M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||||
| Net Income | $1.56B | $479M | $1.35B | $1.34B | $1.46B | $1.14B |
| Depreciation & Amortization | $489M | $555M | $561M | $578M | $597M | $599M |
| Deferred Income Tax | -$120M | -$155M | -$142M | -$141M | -$34M | -$54M |
| Stock-Based Compensation | $161M | $112M | $39M | $37M | $38M | $35M |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $78M | $276M | -$129M | -$32M | -$1M | $41M |
| Inventory | -$139M | -$132M | $23M | -$82M | -$136M | $43M |
| Accounts Payable | $104M | $266M | $105M | $25M | $68M | $10M |
| Other Working Capital | -$162M | -$250M | $127M | -$113M | $136M | $140M |
| Total Working Capital Change | -$119M | $160M | $126M | -$202M | $67M | $234M |
| Other Non-Cash Items | -$1.6B | $34M | -$15M | $64M | $74M | $74M |
| Net Cash from Operating | $369M | $1.19B | $1.92B | $1.68B | $2.2B | $2.03B |
| Investing Activities | ||||||
| Capital Expenditures | -$379M | -$380M | -$290M | -$251M | -$277M | -$271M |
| Acquisitions | -$696M | $0 | $60M | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $469M |
| Other Investing Activities | $3.87B | $0 | $0 | -$2M | -$1M | $30M |
| Net Cash from Investing | $2.8B | -$380M | -$230M | -$253M | -$278M | $228M |
| Financing Activities | ||||||
| Debt Repaid | $3.07B | -$8B | - | - | - | $445M |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $13M | -$8.24B | -$1.55B | -$1.46B | -$1.96B | -$1.77B |
| Net Cash from Financing | -$3.06B | -$240M | -$1.55B | -$1.46B | -$1.96B | -$2.21B |
| Forex Effect | $7M | $3M | $0 | $4M | $3M | -$3M |
| Net Change in Cash | $116M | $568M | $133M | -$30M | -$33M | $40M |
| Supplementary Data | ||||||
| Operating Cash Flow | $369M | $1.19B | $1.92B | $1.68B | $2.2B | $2.03B |
| Capital Expenditure | -$379M | -$380M | -$290M | -$251M | -$277M | -$271M |
| Free Cash Flow | -$10M | $805M | $1.63B | $1.43B | $1.93B | $1.75B |
| Cash at Beginning | $762M | $194M | $61M | $91M | $124M | $84M |
| Cash at End | $878M | $762M | $194M | $61M | $91M | $124M |